800-671-4304Alaska Makes Buprenorphine Access by Telehealth Permanent
Published: 07/29/2026
Alaska has adopted permanent rules for prescribing buprenorphine through telemedicine, giving physicians and people going through medical detox for opioid use disorder a stable, long-term framework instead of temporary emergency measures. The new rules take effect July 4.
Why This Matters for Medical Detox
The Alaska State Medical Board adopted the new regulations on February 26, and the Office of the Lieutenant Governor signed and filed them on June 4.
The rules establish practice standards under Title 12, Chapter 40 of the Alaska Administrative Code, replacing emergency measures that had been in place since the federal Drug Addiction Treatment Act waiver was eliminated.
For people beginning medical detox from opioids, telemedicine access to buprenorphine can mean the difference between starting treatment right away and waiting weeks for an in-person appointment, especially in rural parts of the state.
Understanding Buprenorphine
Buprenorphine is a medication used in medical detox and ongoing treatment for opioid use disorder. It works as a partial opioid agonist, meaning it activates opioid receptors in the brain enough to ease withdrawal symptoms and cravings without producing the same intensity of effects as opioids like heroin or fentanyl.
Combined with counseling, it is one of the FDA-approved medications most commonly used in medication-assisted treatment.
What Changed and Why
Federal rule changes that took effect in January 2025 made permanent certain telemedicine flexibilities for opioid treatment, allowing DEA-registered providers to prescribe buprenorphine via telemedicine for up to six calendar months before requiring an in-person evaluation.
Alaska’s new state-level regulations build on that federal flexibility by repealing outdated language in state law that had restricted buprenorphine prescribing through telemedicine.
The Alaska board published its proposed regulations in September 2025 and accepted public comment through November 3, 2025. ATA Action, a national telehealth advocacy organization, submitted a letter supporting the repeal of the older restrictions.
The state expects no additional implementation costs, and the regulations will be formally published in the Alaska Register in October 2026.
The Bigger Picture on Telemedicine and MAT
Telemedicine flexibility for medication-assisted treatment has been one of the more consequential regulatory shifts in opioid treatment over the past several years.
Before the pandemic-era flexibilities that later became federal policy, providers generally needed to see patients in person before prescribing controlled substances like buprenorphine, a requirement that made starting medical detox harder for people in remote areas.
Alaska’s move to make its own telemedicine rules permanent, rather than relying on temporary extensions, gives providers and patients more certainty going forward.
Finding Medical Detox in Alaska
The new rules are expected to matter most in rural Alaska communities that already rely on telehealth for opioid use disorder treatment because of limited access to in-person providers.
Access will still depend on factors like broadband availability, clinic capacity, and reimbursement policy, which the regulations alone do not solve. You can search detox.com’s directory to find detox centers in your area. Call 800-996-6135 to learn more about your options.
